Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Cyclacel Pharmaceuticals EBIT Margin 2010-2024 | CYCC

Current and historical EBIT (Earnings Before Interest & Taxes) margin for Cyclacel Pharmaceuticals (CYCC) over the last 10 years. The current EBIT profit margin for Cyclacel Pharmaceuticals as of June 30, 2024 is .
  
Cyclacel Pharmaceuticals EBIT Margin Historical Data
Date TTM Revenue TTM EBIT EBIT Margin
2024-06-30 $0.00B $-0.02B inf%
2024-03-31 $0.00B $-0.02B inf%
2016-12-31 $0.00B $-0.01B inf%
2016-09-30 $0.00B $-0.02B inf%
2016-06-30 $0.00B $-0.02B -1500.00%
2016-03-31 $0.00B $-0.02B -1500.00%
2015-12-31 $0.00B $-0.02B -800.00%
2015-09-30 $0.00B $-0.02B -900.00%
2015-06-30 $0.00B $-0.02B -1050.00%
2015-03-31 $0.00B $-0.02B -1150.00%
2014-12-31 $0.00B $-0.02B -2300.00%
2014-09-30 $0.00B $-0.02B -2100.00%
2014-06-30 $0.00B $-0.02B inf%
2014-03-31 $0.00B $-0.02B inf%
2013-12-31 $0.00B $-0.02B inf%
2013-09-30 $0.00B $-0.02B inf%
2013-06-30 $0.00B $-0.02B inf%
2013-03-31 $0.00B $-0.02B inf%
2011-06-30 $0.00B $-0.02B inf%
2011-03-31 $0.00B $-0.02B inf%
2010-12-31 $0.00B $-0.02B inf%
2010-09-30 $0.00B $-0.02B inf%
2010-06-30 $0.00B $-0.02B inf%
2010-03-31 $0.00B $-0.02B inf%
2009-12-31 $0.00B $-0.02B inf%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.001B $0.000B
CYCLACEL is a biopharmaceutical company dedicated to the discovery, development and commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious disorders. Three orally-available Cyclacel drugs are in clinical development. Sapacitabine, a cell cycle modulating nucleoside analog, is in Phase 2 studies for the treatment of acute myeloid leukemia in the elderly, myelodysplastic syndromes and cutaneous T-cell lymphoma. Seliciclib (CYC202 or R-roscovitine), a CDK inhibitor, is in Phase 2 for the treatment of lung cancer and nasopharyngeal cancer.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $160.636B 15.55
Vertex Pharmaceuticals (VRTX) United States $126.189B 0.00
Bristol Myers Squibb (BMY) United States $119.703B 50.44
Gilead Sciences (GILD) United States $117.465B 21.30
Regeneron Pharmaceuticals (REGN) United States $90.219B 20.53
CSL (CSLLY) Australia $89.966B 0.00
GSK (GSK) United Kingdom $73.617B 8.52
Argenex SE (ARGX) Netherlands $35.516B 0.00
Alnylam Pharmaceuticals (ALNY) United States $34.689B 0.00
BioNTech SE (BNTX) Germany $25.489B 0.00
Biogen (BIIB) United States $24.522B 10.53
Illumina (ILMN) United States $23.413B 85.33
BeiGene (BGNE) Cayman Islands $18.860B 0.00
Moderna (MRNA) United States $16.728B 0.00
Incyte (INCY) United States $15.524B 0.00
Genmab (GMAB) Denmark $14.870B 21.82
BioMarin Pharmaceutical (BMRN) United States $12.603B 29.26
Insmed (INSM) United States $12.548B 0.00
Vaxcyte (PCVX) United States $12.386B 0.00
Bio-Techne Corp (TECH) United States $11.823B 45.65
Sarepta Therapeutics (SRPT) United States $10.920B 98.55
Exelixis (EXEL) United States $10.238B 23.28
Revolution Medicines (RVMD) United States $9.980B 0.00
QIAGEN (QGEN) Netherlands $9.865B 20.30
Intra-Cellular Therapies (ITCI) United States $9.381B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.375B 31.86
Exact Sciences (EXAS) United States $9.283B 0.00
Roivant Sciences (ROIV) United Kingdom $8.608B 0.00
Repligen (RGEN) United States $8.322B 108.46
Ascendis Pharma (ASND) Denmark $7.742B 0.00
Halozyme Therapeutics (HALO) United States $7.584B 17.13
Legend Biotech (LEGN) United States $7.325B 0.00
Viking Therapeutics (VKTX) United States $6.753B 0.00
Cytokinetics (CYTK) United States $6.631B 0.00
Blueprint Medicines (BPMC) United States $6.138B 0.00
Nuvalent (NUVL) United States $5.896B 0.00
Avidity Biosciences (RNA) United States $5.575B 0.00
Arcellx (ACLX) United States $5.433B 0.00
Krystal Biotech (KRYS) United States $5.385B 89.15
ADMA Biologics Inc (ADMA) United States $5.077B 54.45
Biohaven (BHVN) United States $4.761B 0.00
Alkermes (ALKS) Ireland $4.729B 15.89
Axsome Therapeutics (AXSM) United States $4.725B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.418B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.330B 0.00
Denali Therapeutics (DNLI) United States $4.302B 0.00
Immunovant (IMVT) United States $4.296B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.937B 0.00
Guardant Health (GH) United States $3.673B 0.00
Apellis Pharmaceuticals (APLS) United States $3.640B 0.00
Merus (MRUS) Netherlands $3.535B 0.00
ImmunityBio (IBRX) United States $3.448B 0.00
Edgewise Therapeutics (EWTX) United States $3.333B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.315B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.287B 0.00
Kymera Therapeutics (KYMR) United States $3.238B 0.00
Amicus Therapeutics (FOLD) United States $3.134B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $3.118B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.047B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.983B 22.99
Iovance Biotherapeutics (IOVA) United States $2.953B 0.00
Zai Lab (ZLAB) China $2.885B 0.00
Janux Therapeutics (JANX) United States $2.773B 0.00
Vericel (VCEL) United States $2.759B 931.50
IDEAYA Biosciences (IDYA) United States $2.678B 0.00
Vera Therapeutics (VERA) United States $2.661B 0.00
Twist Bioscience (TWST) United States $2.652B 0.00
Keros Therapeutics (KROS) United States $2.628B 0.00
Apogee Therapeutics (APGE) United States $2.581B 0.00
Protagonist Therapeutics (PTGX) United States $2.573B 16.23
Belite Bio (BLTE) United States $2.484B 0.00
CG Oncology (CGON) United States $2.481B 0.00
SpringWorks Therapeutics (SWTX) United States $2.458B 0.00
Geron (GERN) United States $2.400B 0.00
Longboard Pharmaceuticals (LBPH) United States $2.323B 0.00
Beam Therapeutics (BEAM) United States $2.314B 0.00
Ligand Pharmaceuticals (LGND) United States $2.281B 56.95
Bavarian Nordic (BVNRY) Denmark $2.277B 12.19
Akero Therapeutics (AKRO) United States $2.260B 0.00
Scholar Rock Holding (SRRK) United States $2.134B 0.00
Structure Therapeutics (GPCR) United States $2.115B 0.00
NeoGenomics (NEO) United States $2.096B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.017B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.001B 16.63
WAVE Life Sciences (WVE) Singapore $1.982B 0.00
Fortrea Holdings (FTRE) United States $1.969B 62.71
MannKind (MNKD) United States $1.953B 50.57
NovoCure (NVCR) Jersey $1.928B 0.00
Nurix Therapeutics (NRIX) United States $1.915B 0.00
Disc Medicine (IRON) United States $1.880B 0.00
Spyre Therapeutics (SYRE) United States $1.842B 0.00
Neumora Therapeutics (NMRA) United States $1.810B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.810B 0.00
Arvinas (ARVN) United States $1.808B 0.00
Galapagos (GLPG) Belgium $1.800B 0.00
Celldex Therapeutics (CLDX) United States $1.792B 0.00
Dynavax Technologies (DVAX) United States $1.775B 103.85
Certara (CERT) United States $1.706B 48.18
Intellia Therapeutics (NTLA) United States $1.696B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.688B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.660B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.577B 0.00
Praxis Precision Medicines (PRAX) United States $1.546B 0.00
Arcus Biosciences (RCUS) United States $1.535B 0.00
Gyre Therapeutics (GYRE) United States $1.496B 0.00
Myriad Genetics (MYGN) United States $1.472B 0.00
Travere Therapeutics (TVTX) United States $1.463B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.461B 0.00
Kura Oncology (KURA) United States $1.444B 0.00
Viridian Therapeutics (VRDN) United States $1.433B 0.00
Upstream Bio (UPB) United States $1.414B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.384B 0.00
Novavax (NVAX) United States $1.354B 0.00
ANI Pharmaceuticals (ANIP) United States $1.284B 17.48
Vir Biotechnology (VIR) United States $1.274B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.200B 0.00
Zymeworks (ZYME) United States $1.198B 0.00
Bicara Therapeutics (BCAX) United States $1.157B 0.00
Applied Therapeutics (APLT) United States $1.152B 0.00
Cogent Biosciences (COGT) United States $1.136B 0.00
Mesoblast (MESO) Australia $1.136B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.114B 0.00
ArriVent BioPharma (AVBP) United States $1.108B 0.00
MiMedx (MDXG) United States $1.096B 28.69
LENZ Therapeutics (LENZ) United States $1.024B 0.00
Immatics (IMTX) Germany $1.012B 0.00
Septerna (SEPN) $0.990B 0.00
CARGO Therapeutics (CRGX) United States $0.970B 0.00
89BIO (ETNB) United States $0.960B 0.00
Prothena (PRTA) Ireland $0.934B 0.00
Cullinan Therapeutics (CGEM) United States $0.933B 0.00
Castle Biosciences (CSTL) United States $0.918B 163.90
Cytek Biosciences (CTKB) United States $0.907B 0.00
Rapport Therapeutics (RAPP) United States $0.887B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.886B 0.00
Adaptive Biotechnologies (ADPT) United States $0.875B 0.00
AbCellera Biologics (ABCL) Canada $0.874B 0.00
Erasca (ERAS) United States $0.845B 0.00
Pliant Therapeutics (PLRX) United States $0.841B 0.00
Replimune (REPL) United States $0.833B 0.00
Zenas BioPharma (ZBIO) United States $0.820B 0.00
Dianthus Therapeutics (DNTH) United States $0.819B 0.00
Liquidia Technologies (LQDA) United States $0.816B 0.00
Tyra Biosciences (TYRA) United States $0.807B 0.00
Avid Bioservices (CDMO) United States $0.780B 0.00
Pacira BioSciences (PCRX) United States $0.776B 7.30
Anavex Life Sciences (AVXL) United States $0.765B 0.00
MBX Biosciences (MBX) United States $0.759B 0.00
Immunome (IMNM) United States $0.750B 0.00
Entrada Therapeutics (TRDA) United States $0.741B 12.45
Nuvation Bio (NUVB) United States $0.730B 0.00
Oric Pharmaceuticals (ORIC) United States $0.724B 0.00
Stoke Therapeutics (STOK) United States $0.721B 0.00
BioAge Labs (BIOA) United States $0.717B 0.00
CorMedix Inc (CRMD) United States $0.708B 0.00
Tectonic Therapeutic (TECX) United States $0.704B 0.00
Annexon (ANNX) United States $0.698B 0.00
Arbutus Biopharma (ABUS) United States $0.690B 0.00
Third Harmonic Bio (THRD) United States $0.678B 0.00
IGM Biosciences (IGMS) United States $0.673B 0.00
Mineralys Therapeutics (MLYS) United States $0.665B 0.00
Olema Pharmaceuticals (OLMA) United States $0.661B 0.00
AnaptysBio (ANAB) United States $0.654B 0.00
Abivax SA (ABVX) France $0.654B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.651B 0.00
CureVac (CVAC) Germany $0.645B 5.24
Sinovac Biotech (SVA) China $0.645B 0.00
Humacyte (HUMA) United States $0.640B 0.00
Sana Biotechnology (SANA) United States $0.634B 0.00
Astria Therapeutics (ATXS) United States $0.630B 0.00
Oculis Holding AG (OCS) Switzerland $0.607B 0.00
Allogene Therapeutics (ALLO) United States $0.595B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.595B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.591B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.590B 0.00
Emergent Biosolutions (EBS) United States $0.590B 0.00
ACELYRIN, INC (SLRN) United States $0.587B 0.00
Sangamo Therapeutics (SGMO) United States $0.564B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.561B 0.00
ChromaDex (CDXC) United States $0.554B 725.00
Celcuity (CELC) United States $0.553B 0.00
PureTech Health (PRTC) United States $0.547B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.544B 0.00
Alector (ALEC) United States $0.544B 0.00
Pharming Group (PHAR) Netherlands $0.543B 0.00
Alumis (ALMS) United States $0.536B 0.00
Q32 Bio (QTTB) United States $0.532B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.530B 0.00
Aura Biosciences (AURA) United States $0.528B 0.00
Neurogene (NGNE) United States $0.520B 0.00
REGENXBIO (RGNX) United States $0.520B 0.00
Prime Medicine (PRME) United States $0.519B 0.00
Contineum Therapeutics (CTNM) United States $0.505B 0.00
Terns Pharmaceuticals (TERN) United States $0.504B 0.00
Foghorn Therapeutics (FHTX) United States $0.493B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.491B 0.00
GH Research (GHRS) Ireland $0.476B 0.00
GRAIL (GRAL) United States $0.469B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.466B 0.00
Revance Therapeutics (RVNC) United States $0.433B 0.00
MeiraGTx Holdings (MGTX) United States $0.432B 0.00
Cartesian Therapeutics (RNAC) United States $0.430B 0.00
BioStem Technologies (BSEM) $0.415B 36.74
Absci (ABSI) United States $0.413B 0.00
Northwest Biotherapeutics (NWBO) United States $0.399B 0.00
Design Therapeutics (DSGN) United States $0.391B 0.00
C4 Therapeutics (CCCC) United States $0.389B 0.00
EnGene Holdings (ENGN) Canada $0.377B 0.00
MaxCyte (MXCT) United States $0.373B 0.00
Voyager Therapeutics (VYGR) United States $0.372B 9.62
XOMA Royalty (XOMA) United States $0.368B 0.00
Jasper Therapeutics (JSPR) United States $0.361B 0.00
Kamada (KMDA) Israel $0.360B 23.22
Tango Therapeutics (TNGX) United States $0.360B 0.00
Poseida Therapeutics (PSTX) United States $0.360B 0.00
Alpha Teknova (TKNO) United States $0.340B 0.00
Rezolute (RZLT) United States $0.337B 0.00
ITeos Therapeutics (ITOS) United States $0.336B 0.00
Sutro Biopharma (STRO) United States $0.334B 0.00
UniQure (QURE) Netherlands $0.328B 0.00
Codexis (CDXS) United States $0.327B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.325B 0.00
Semper Paratus Acquisition (TVGN) United States $0.323B 0.00
Artiva Biotherapeutics (ARTV) United States $0.317B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.315B 0.00
Nautilus Biotechnology (NAUT) United States $0.313B 0.00
Zura Bio (ZURA) United States $0.304B 0.00
AC Immune (ACIU) Switzerland $0.303B 0.00
Ocugen (OCGN) United States $0.294B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.293B 0.00
ATyr Pharma (ATYR) United States $0.293B 0.00
Biomea Fusion (BMEA) United States $0.290B 0.00
Urogen Pharma (URGN) United States $0.290B 0.00
Prima BioMed (IMMP) Australia $0.288B 0.00
TScan Therapeutics (TCRX) United States $0.287B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.283B 0.00
Atea Pharmaceuticals (AVIR) United States $0.281B 0.00
Fate Therapeutics (FATE) United States $0.271B 0.00
Mersana Therapeutics (MRSN) United States $0.270B 0.00
Kodiak Sciences (KOD) United States $0.267B 0.00
Abeona Therapeutics (ABEO) United States $0.264B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.264B 0.00
GENFIT S.A (GNFT) France $0.260B 0.00
Lifecore Biomedical (LFCR) United States $0.259B 0.00
Climb Bio (CLYM) United States $0.255B 0.00
Editas Medicine (EDIT) United States $0.253B 0.00
Anika Therapeutics (ANIK) United States $0.247B 0.00
Compass Therapeutics (CMPX) United States $0.246B 0.00
Inozyme Pharma (INZY) United States $0.242B 0.00
Opthea (OPT) Australia $0.241B 0.00
Precigen (PGEN) United States $0.240B 0.00
Inhibrx Biosciences (INBX) United States $0.240B 0.00
Eton Pharmaceuticals (ETON) United States $0.237B 0.00
Trevi Therapeutics (TRVI) United States $0.231B 0.00
CAMP4 Therapeutics (CAMP) United States $0.229B 0.00
Fulcrum Therapeutics (FULC) United States $0.227B 0.00
Amarin (AMRN) Ireland $0.227B 0.00
Kyverna Therapeutics (KYTX) United States $0.225B 0.00
2seventy Bio (TSVT) United States $0.220B 0.00
Solid Biosciences (SLDB) United States $0.220B 0.00
Instil Bio (TIL) United States $0.217B 0.00
XBiotech (XBIT) United States $0.216B 0.00
Nkarta (NKTX) United States $0.215B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.214B 0.00
Caribou Biosciences (CRBU) United States $0.212B 0.00
Nuvectis Pharma (NVCT) United States $0.212B 0.00
Cabaletta Bio (CABA) United States $0.210B 0.00
Molecular Partners AG (MOLN) Switzerland $0.209B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.203B 0.00
ScPharmaceuticals (SCPH) United States $0.197B 0.00
Verastem (VSTM) United States $0.196B 0.00
Gossamer Bio (GOSS) United States $0.192B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.191B 0.00
DiaMedica Therapeutics (DMAC) United States $0.184B 0.00
Black Diamond Therapeutics (BDTX) United States $0.183B 0.00
Sagimet Biosciences (SGMT) United States $0.182B 0.00
Greenwich LifeSciences (GLSI) United States $0.178B 0.00
Actuate Therapeutics (ACTU) United States $0.176B 0.00
Bright Minds Biosciences (DRUG) United States $0.176B 0.00
Tenaya Therapeutics (TNYA) United States $0.175B 0.00
Adverum Biotechnologies (ADVM) United States $0.164B 0.00
Skye Bioscience (SKYE) United States $0.164B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.161B 0.00
Cardiff Oncology (CRDF) United States $0.161B 0.00
Akoya Biosciences (AKYA) United States $0.158B 0.00
Puma Biotechnology (PBYI) United States $0.158B 6.69
Checkpoint Therapeutics (CKPT) United States $0.155B 0.00
Innate Pharma S.A (IPHA) France $0.154B 0.00
Repare Therapeutics (RPTX) Canada $0.149B 0.00
Ventyx Biosciences (VTYX) United States $0.148B 0.00
Oncobiologics (OTLK) United States $0.148B 0.00
PepGen (PEPG) United States $0.148B 0.00
Scilex Holding (SCLX) United States $0.148B 0.00
Vigil Neuroscience (VIGL) United States $0.147B 0.00
Candel Therapeutics (CADL) United States $0.143B 0.00
Compugen (CGEN) Israel $0.143B 80.00
Seer (SEER) United States $0.139B 0.00
Inventiva S.A (IVA) France $0.139B 0.00
Rani Therapeutics Holdings (RANI) United States $0.137B 0.00
Generation Bio (GBIO) United States $0.137B 0.00
Inovio Pharmaceuticals (INO) United States $0.134B 0.00
Elutia (ELUT) United States $0.129B 0.00
INmune Bio (INMB) United States $0.126B 0.00
Allakos (ALLK) United States $0.122B 0.00
Alto Neuroscience (ANRO) United States $0.121B 0.00
Coya Therapeutics (COYA) United States $0.121B 0.00
Invivyd (IVVD) United States $0.119B 0.00
Adherex Technologies (FENC) United States $0.116B 0.00
23andMe Holding (ME) United States $0.115B 0.00
Adlai Nortye (ANL) Cayman Islands $0.115B 0.00
Benitec Biopharma (BNTC) United States $0.115B 0.00
Seres Therapeutics (MCRB) United States $0.113B 0.00
MediciNova (MNOV) United States $0.112B 0.00
FibroBiologics (FBLG) United States $0.111B 0.00
Cellectis S.A (CLLS) France $0.110B 0.00
PDS Biotechnology (PDSB) United States $0.109B 0.00
Adagene (ADAG) China $0.108B 0.00
BioAtla (BCAB) United States $0.106B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.105B 0.00
Annovis Bio (ANVS) United States $0.104B 0.00
Immunic (IMUX) United States $0.104B 0.00
Genelux (GNLX) United States $0.102B 0.00
Renovaro (RENB) United States $0.102B 0.00
X4 Pharmaceuticals (XFOR) United States $0.100B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.100B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.099B 0.00
Adicet Bio (ACET) United States $0.099B 0.00
HilleVax (HLVX) United States $0.099B 0.00
Werewolf Therapeutics (HOWL) United States $0.096B 0.00
Coherus BioSciences (CHRS) United States $0.095B 0.00
Cidara Therapeutics (CDTX) United States $0.095B 0.00
Monopar Therapeutics (MNPR) United States $0.091B 0.00
Chimerix (CMRX) United States $0.089B 0.00
InflaRx (IFRX) Germany $0.089B 0.00
Ovid Therapeutics (OVID) United States $0.088B 0.00
Genenta Science S.p.A (GNTA) Italy $0.088B 0.00
Galena Biopharma (SLS) United States $0.087B 0.00
I-Mab (IMAB) China $0.086B 0.00
Oncolytics Biotech (ONCY) Canada $0.086B 0.00
Ikena Oncology (IKNA) United States $0.085B 0.00
Celularity (CELU) United States $0.084B 0.00
Leap Therapeutics (LPTX) United States $0.083B 0.00
Aileron Therapeutics (ALRN) United States $0.083B 0.00
Clearside Biomedical (CLSD) United States $0.083B 0.00
Cue Biopharma (CUE) United States $0.083B 0.00
Boundless Bio (BOLD) United States $0.083B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.082B 0.00
VistaGen Therapeutics (VTGN) United States $0.082B 0.00
CytomX Therapeutics (CTMX) United States $0.081B 6.12
Eupraxia Pharmaceuticals (EPRX) Canada $0.079B 0.00
TELA Bio (TELA) United States $0.077B 0.00
Aerovate Therapeutics (AVTE) United States $0.077B 0.00
Bluebird Bio (BLUE) United States $0.076B 0.00
ZIVO Bioscience (ZIVO) United States $0.074B 0.00
Syros Pharmaceuticals (SYRS) United States $0.073B 0.00
CervoMed (CRVO) United States $0.073B 0.00
Quince Therapeutics (QNCX) United States $0.073B 0.00
BeyondSpring (BYSI) United States $0.073B 0.00
Spero Therapeutics (SPRO) United States $0.071B 3.22
ALX Oncology Holdings (ALXO) United States $0.071B 0.00
Vor Biopharma (VOR) $0.068B 0.00
Agenus (AGEN) United States $0.067B 0.00
Precision BioSciences (DTIL) United States $0.064B 0.00
Omega Therapeutics (OMGA) United States $0.063B 0.00
DBV Technologies S.A (DBVT) France $0.061B 0.00
IO Biotech (IOBT) Denmark $0.061B 0.00
Rapt Therapeutics (RAPT) United States $0.061B 0.00
Enzo Biochem (ENZ) United States $0.061B 0.00
Shattuck Labs (STTK) United States $0.060B 0.00
Entera Bio (ENTX) Israel $0.060B 0.00
Theratechnologies (THTX) Canada $0.058B 0.00
OnKure Therapeutics (OKUR) United States $0.058B 0.00
Connect Biopharma Holdings (CNTB) United States $0.057B 0.00
Atara Biotherapeutics (ATRA) United States $0.057B 0.00
Affimed (AFMD) Germany $0.057B 0.00
Aligos Therapeutics (ALGS) United States $0.057B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.056B 0.00
Kronos Bio (KRON) United States $0.055B 0.00
Kezar Life Sciences (KZR) United States $0.055B 0.00
Immuneering (IMRX) United States $0.054B 0.00
Elicio Therapeutics (ELTX) United States $0.054B 0.00
Aadi Bioscience (AADI) United States $0.053B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.051B 0.00
Xilio Therapeutics (XLO) United States $0.047B 0.00
Immix Biopharma (IMMX) United States $0.047B 0.00
BGM Group (BGM) China $0.047B 0.00
Intensity Therapeutics (INTS) United States $0.047B 0.00
Imunon (IMNN) United States $0.047B 0.00
Rallybio (RLYB) United States $0.046B 0.00
HOOKIPA Pharma (HOOK) United States $0.043B 0.00
NextCure (NXTC) United States $0.043B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.043B 0.00
VTv Therapeutics (VTVT) United States $0.042B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.042B 0.00
Passage Bio (PASG) United States $0.041B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.041B 0.00
Elevation Oncology (ELEV) United States $0.041B 0.00
Fortress Biotech (FBIO) United States $0.039B 0.00
Lantern Pharma (LTRN) United States $0.039B 0.00
Lumos Pharma (LUMO) United States $0.038B 0.00
Dare Bioscience (DARE) United States $0.038B 0.00
CalciMedica (CALC) United States $0.038B 0.00
OKYO Pharma (OKYO) $0.037B 0.00
Lexaria Bioscience (LEXX) Canada $0.036B 0.00
Clene (CLNN) United States $0.036B 0.00
Dyadic (DYAI) United States $0.034B 0.00
Longeveron (LGVN) United States $0.033B 0.00
KALA BIO (KALA) United States $0.033B 0.00
Eyenovia (EYEN) United States $0.032B 0.00
Grace Therapeutics (GRCE) Canada $0.032B 0.00
AN2 Therapeutics (ANTX) United States $0.032B 0.00
SAB Biotherapeutics (SABS) United States $0.032B 0.00
Athira Pharma (ATHA) United States $0.031B 0.00
MiNK Therapeutics (INKT) United States $0.031B 0.00
Pluri (PLUR) Israel $0.030B 0.00
Equillium (EQ) United States $0.030B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.030B 0.00
Opus Genetics (IRD) United States $0.030B 0.00
LakeShore Biopharma (LSB) China $0.029B 0.00
Promis Neurosciences (PMN) Canada $0.029B 0.00
Estrella Immunopharma (ESLA) United States $0.029B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.028B 0.00
GeoVax Labs (GOVX) United States $0.027B 0.00
BioXcel Therapeutics (BTAI) United States $0.027B 0.00
Chemomab Therapeutics (CMMB) Israel $0.027B 0.00
RenovoRx (RNXT) United States $0.026B 0.00
Ocean Biomedical (OCEA) United States $0.026B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.025B 0.00
Curis (CRIS) United States $0.025B 0.00
Bolt Biotherapeutics (BOLT) United States $0.025B 0.00
Lisata Therapeutics (LSTA) United States $0.024B 0.00
Cognition Therapeutics (CGTX) United States $0.024B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.024B 0.00
Beyond Air (XAIR) United States $0.023B 0.00
BRIACELL THERAP (BCTX) Canada $0.023B 0.00
Femasys (FEMY) United States $0.023B 0.00
Bionano Genomics (BNGO) United States $0.023B 0.00
UNITY Biotechnology (UBX) United States $0.022B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.022B 0.00
Spruce Biosciences (SPRB) United States $0.022B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.021B 0.00
Cyclo Therapeutics (CYTH) United States $0.021B 0.00
Gelteq (GELS) $0.021B 0.00
Cadrenal Therapeutics (CVKD) United States $0.019B 0.00
Cara Therapeutics (CARA) United States $0.019B 0.00
Aprea Therapeutics (APRE) United States $0.019B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.018B 0.00
Cocrystal Pharma (COCP) United States $0.018B 0.00
BioAffinity Technologies (BIAF) United States $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
Novogen (KZIA) Australia $0.017B 0.00
Tenax Therapeutics (TENX) United States $0.017B 0.00
IN8bio (INAB) United States $0.016B 0.00
Sensei Biotherapeutics (SNSE) United States $0.014B 0.00
Cingulate (CING) United States $0.013B 0.00
Turnstone Biologics (TSBX) United States $0.013B 0.00
Evaxion Biotech (EVAX) Denmark $0.013B 0.00
Apollomics (APLM) United States $0.013B 0.00
HCW Biologics (HCWB) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Aytu BioPharma (AYTU) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Evogene (EVGN) Israel $0.011B 0.00
Senti Biosciences (SNTI) United States $0.010B 0.00
Vincerx Pharma (VINC) United States $0.010B 0.00
Biora Therapeutics (BIOR) United States $0.010B 0.00
Mustang Bio (MBIO) United States $0.010B 0.00
Galecto (GLTO) Denmark $0.009B 0.00
NKGen Biotech (NKGN) United States $0.009B 0.00
Soligenix (SNGX) United States $0.009B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.008B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.008B 0.00
Forte Biosciences (FBRX) United States $0.008B 0.00
Moleculin Biotech (MBRX) United States $0.008B 0.00
TuHURA Biosciences (HURA) United States $0.008B 0.00
Edesa Biotech (EDSA) Canada $0.008B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
Aptose Biosciences (APTO) Canada $0.007B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Quantum Biopharma (QNTM) Canada $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.006B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.006B 0.00
TFF Pharmaceuticals (TFFP) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Alzamend Neuro (ALZN) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
Eterna Therapeutics (ERNA) United States $0.006B 0.00
Carmell (CTCX) United States $0.006B 0.00
Vaccinex (VCNX) United States $0.006B 0.00
Exicure (XCUR) United States $0.006B 0.00
Organovo Holdings (ONVO) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Bionomics (BNOX) Australia $0.005B 0.00
GENPREX (GNPX) United States $0.005B 0.00
Cyclerion Therapeutics (CYCN) United States $0.005B 0.00
Biofrontera (BFRI) United States $0.005B 0.00
BioCardia (BCDA) United States $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.005B 0.00
Dogwood Therapeutics (DWTX) United States $0.005B 0.00
Polyrizon (PLRZ) $0.005B 0.00
Psyence Biomedical (PBM) Canada $0.004B 0.00
Portage Biotech (PRTG) $0.004B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
NuCana (NCNA) United Kingdom $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Purple Biotech (PPBT) Israel $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Silexion Therapeutics Corp (SLXN) United States $0.004B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
Pasithea Therapeutics (KTTA) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
NAYA Biosciences (NAYA) United States $0.003B 0.00
Sunshine Biopharma (SBFM) United States $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Citius Oncology (CTOR) United States $0.003B 0.00
180 Life Sciences (ATNF) United States $0.003B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.003B 0.00
GRI Bio (GRI) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.002B 0.00
Allarity Therapeutics (ALLR) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Revelation Biosciences (REVB) United States $0.002B 0.00
Onconetix (ONCO) United States $0.001B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.001B 0.00
Elevai Labs (ELAB) United States $0.000B 0.00
Windtree Therapeutics (WINT) United States $0.000B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) Luxembourg $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00